Technology | Quality Assurance (QA) | November 24, 2015

Realistic Male Bladder and Prostate Imaging Phantom Released

Phantom designed for abdominal and transrectal applications requiring multiple modalities including CT, MRI and ultrasound
 

CIRS, Multi-Modality Male Pelvic Phantom, realistic abdominal and transrectal scanning

Image courtesy of CIRS Inc.

November 24, 2015 — The CIRS Multi-Modality Male Pelvic Phantom was designed for realistic abdominal and transrectal ultrasound scanning of the bladder and prostate. The phantom includes pelvic bones, anechoic bladder, prostate, urethra, seminal vesicles and rectum enclosed in a pelvic-shaped plastic housing with a Z-Skin membrane. The self-healing qualities of Z-Skin make this design ideal for the demonstration of biopsies and other image-guided procedures.

The phantom is made from materials that can be imaged under ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT), making the phantom useful for applications that require multiple modalities such as radiation treatment planning. The phantom is provided with certified prostate and bladder volumes to enable assessment of volumetric measurement accuracy.

Modifications are available such as permanently embedded brachytherapy “dummy” seeds or gold fiducial markers for demonstration of target visualization.

Each phantom is sold with a certificate of compliance.

For more information: www.cirsinc.com

Related Content

A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
February 15, 2018 — Arterys Inc. announced its fifth 510(k) clearance from the U.S.
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Videos | Enterprise Imaging | February 13, 2018
ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of...
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
Planmed Launches Improved Planmed Verity CBCT Scanner
Technology | Computed Tomography (CT) | February 07, 2018
Planmed announced the launch of the improved Planmed Verity cone beam computed tomography (CBCT) scanner for orthopedic...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Overlay Init